Yüklüyor......
An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein mediates viral entry into cells expressing angiotensin-converting enzyme 2 (ACE2). The S protein engages ACE2 through its receptor-binding domain (RBD), an independently folded 197-amino-acid fragment of the 1,273-ami...
Kaydedildi:
| Yayımlandı: | mBio |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8262850/ https://ncbi.nlm.nih.gov/pubmed/33975938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/mBio.00930-21 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|